» Articles » PMID: 16271806

Regionally Specific Atrophy of the Corpus Callosum in AD, MCI and Cognitive Complaints

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 2005 Nov 8
PMID 16271806
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of the present study was to determine if there are global or regionally specific decreases in callosal area in early Alzheimer's disease (AD) and mild cognitive impairment (MCI). In addition, this study examined the corpus callosum of healthy older adults who have subjective cognitive complaints (CC) but perform within normal limits on neuropsychological tests. We used a semi-automated procedure to examine the total and regional areas of the corpus callosum in 22 patients with early AD, 28 patients with amnestic MCI, 28 healthy older adults with cognitive complaints, and 50 demographically matched healthy controls (HC). The AD, MCI, and CC groups all showed a significant reduction of the posterior region (isthmus and splenium) relative to healthy controls. The AD group also had a significantly smaller overall callosum than the controls. The demonstration of callosal atrophy in older adults with cognitive complaints suggests that callosal changes occur very early in the dementing process, and that these earliest changes may be too subtle for detection by neuropsychological assessments, including memory tests.

Citing Articles

Mapping hippocampal glutamate in healthy aging with glutamate-weighted CEST (GluCEST) imaging.

Pecsok M, Robinson H, Atkins A, Calkins M, Elliott M, Mordy A Front Aging Neurosci. 2025; 16:1535158.

PMID: 39926356 PMC: 11802501. DOI: 10.3389/fnagi.2024.1535158.


White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis.

Wei Y, Kung Y, Lin C, Chen C, Lin C, Tseng R Behav Brain Funct. 2024; 20(1):12.

PMID: 38778325 PMC: 11110460. DOI: 10.1186/s12993-024-00238-x.


Predicting daily cognition and lifestyle behaviors for older adults using smart home data and ecological momentary assessment.

Schmitter-Edgecombe M, Luna C, Dai S, Cook D Clin Neuropsychol. 2024; :1-25.

PMID: 38503715 PMC: 11411016. DOI: 10.1080/13854046.2024.2330143.


Brain white matter microstructural changes in chemotherapy-treated older long-term breast cancer survivors.

Daniel E, Deng F, Patel S, Sedrak M, Kim H, Razavi M Cancer Med. 2023; 13(1):e6881.

PMID: 38152038 PMC: 10807556. DOI: 10.1002/cam4.6881.


Whole-brain structure-function coupling abnormalities in mild cognitive impairment: a study combining amplitude of low-frequency fluctuations and voxel-based morphometry.

Zhao R, Wang P, Liu L, Zhang F, Hu P, Wen J Front Neurosci. 2023; 17:1236221.

PMID: 37583417 PMC: 10424122. DOI: 10.3389/fnins.2023.1236221.


References
1.
Alexander G, Chen K, Pietrini P, Rapoport S, Reiman E . Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am J Psychiatry. 2002; 159(5):738-45. DOI: 10.1176/appi.ajp.159.5.738. View

2.
Dorion A, Sarazin M, Hasboun D, Hahn-Barma V, Dubois B, Zouaoui A . Relationship between attentional performance and corpus callosum morphometry in patients with Alzheimer's disease. Neuropsychologia. 2002; 40(7):946-56. DOI: 10.1016/s0028-3932(01)00150-6. View

3.
Hensel A, Wolf H, Kruggel F, Riedel-Heller S, Nikolaus C, Arendt T . Morphometry of the corpus callosum in patients with questionable and mild dementia. J Neurol Neurosurg Psychiatry. 2002; 73(1):59-61. PMC: 1757286. DOI: 10.1136/jnnp.73.1.59. View

4.
Takahashi S, Yonezawa H, Takahashi J, Kudo M, Inoue T, Tohgi H . Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett. 2002; 332(1):45-8. DOI: 10.1016/s0304-3940(02)00914-x. View

5.
Teipel S, Bayer W, Alexander G, Bokde A, Zebuhr Y, Teichberg D . Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging. 2002; 24(1):85-94. DOI: 10.1016/s0197-4580(02)00044-1. View